Sumeirui (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Nanjing Youke Pharmaceutical Co., Ltd. | GLT

Generic Information: Sumeirui (Baricitinib) — Nanjing Youke, China

Sumeirui is a domestically produced generic baricitinib from Nanjing Youke Pharmaceutical Co., Ltd., a Chinese manufacturer. It is registered in China under the approval number 国药准字H20234188, meaning it has passed China's national drug evaluation and is produced to local GMP standards. Sumeirui delivers the same JAK1/JAK2 inhibitor as the originator Olumiant in a 2 mg tablet, packed 28 to a box — a lower-cost option within China's own regulated supply chain.

What Is Sumeirui (Baricitinib) Used For?

Sumeirui is used for immune-mediated inflammatory conditions, as a generic equivalent of Olumiant:

• Rheumatoid arthritis — moderate to severe active disease in adults with an inadequate DMARD response.
• Atopic dermatitis — moderate to severe eczema in adults and children 2 years and older.
• Severe alopecia areata — extensive patchy hair loss in adults.

How Does Sumeirui (Baricitinib) Work?

Sumeirui's active ingredient, baricitinib, blocks the JAK1 and JAK2 enzymes that relay inflammatory signals inside immune cells. By interrupting the JAK-STAT pathway, it calms the immune overactivity behind rheumatoid arthritis, eczema and alopecia areata. Because it is a generic of Olumiant, its mechanism and effect are the same.

Indications

• Moderate to severe active rheumatoid arthritis in adults
• Moderate to severe atopic dermatitis in adults and children 2+ years
• Severe alopecia areata in adults

Dosage & Administration

Sumeirui is taken as one 2 mg tablet once daily, with or without food; the pack of 28 covers four weeks. The dose may rise to 4 mg daily for rheumatoid arthritis in selected patients or for more severe eczema and alopecia. Swallow whole, adjust for kidney impairment, and follow your physician's instructions.

Side Effects

Common side effects are upper respiratory tract infections, nausea, cold sores and headache. Serious risks include serious infections (tuberculosis, shingles), blood clots, major cardiovascular events, bowel perforation and certain cancers. A boxed warning covers these risks, and a tuberculosis test is advised before treatment.

Storage & Handling

Store Sumeirui tablets at room temperature below 30 °C in the original packaging, protected from moisture and sunlight, and out of reach of children.

Why Choose Sumeirui (Generic Baricitinib)?

• Registered Chinese generic — approved under 国药准字H20234188, produced to China's GMP standards.
• Lower-cost option — the same baricitinib active ingredient as Olumiant at a domestic-generic price.
• Nanjing Youke manufacturing — a Chinese pharmaceutical maker with regulated production.
• GLT supply — GIVE LIFE TIME LIMITED ships batch-traceable Sumeirui with documentation worldwide.

How to Order Sumeirui (Baricitinib) from GLT?

1. Contact GLT on WhatsApp +86 15234153837 or email [email protected] with the quantity required.
2. Receive a formal quotation, payment instructions and delivery estimate.
3. Pay via our secured channel (Hao Yi Lian / 好易联).
4. Goods are dispatched with batch records and tracked until delivery.

We serve licensed institutions and individual patients; a valid prescription may be requested before dispatch.

FAQ

1. Is Sumeirui a generic of baricitinib?

Yes. Sumeirui is a domestically produced Chinese generic baricitinib made by Nanjing Youke, containing the same active ingredient as Olumiant.

2. What is the price of Sumeirui (generic baricitinib)?

As a Chinese generic it is priced below the originator. Contact GLT for a quotation based on your quantity and destination.

3. What is Sumeirui's approval number?

Sumeirui is registered in China under approval number 国药准字H20234188.

4. Where can I buy generic baricitinib?

You can order Sumeirui and other generic baricitinib brands through GLT via WhatsApp +86 15234153837 or email [email protected].

5. Does Sumeirui require a prescription?

Yes, baricitinib is a prescription medicine, and a valid prescription may be requested before dispatch.